Brought to you by 
J&J's Janssen R&D LLC buys Aragon Pharmaceuticals
26 Aug 2020
Executive Summary
Johnson & Johnson's Janssen R&D LLC has acquired closely held Aragon Pharmaceuticals Inc. (hormonally-driven cancer therapeutics) for $650mm in cash up front, plus earn-outs upon reaching development milestones of up to $350mm.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Acquisition
- Acquisition of Private Biotech
- Full Acquisition
- Includes Earnout
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
J&J's Janssen R&D LLC buys Aragon Pharmaceuticals
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice